Infekční endokarditida: Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe

Cor et Vasa

Volumn 49, Issue 11 SUPPL., 2007, Pages 106-120

  Beneš, Jiří ^a   Gregor, Pavel ^b   Mokráček, Aleš ^c  

^a Nemocnice Na Bulovce   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Hospital Ceske Budejovice As   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35948973574     PISSN: 00108650     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Beneš J, Kvasnička J. Infekční endokarditida (Doporučeni pro...). Cor Vasa 2000;42:K21-8.
2. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis. ESC guidelines. Eur Heart J 2004;25:1-37.
3. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis. Diagnosis, antimicrobial therapy, and management of complications. AHA scientific statement. Circulation 2005; 111:e394-e433.
4. Durack DT, Lukes AS, Bright DK. New criteria for the diagnosis of infective endocarditis: utilization of specific echocardiografic findings. Am J Med 1994;96:200-9.
5. Erbel R, Rohmann S, Drexler M, et al. Improved diagnostic value of echokardiography in patiens with infective endocarditis by transesofageal approach. A prospective study. Eur Heart J 1988;9:43-53.
6. Birmingham GD, Rahko PS, Ballantyne F. Improved detection of infective endocarditis with transesophageal echocardiography. Am Heart J 1992;123:774-81.
7. SanRoman JA, Vilacosta I, Zamorano JL, et al. Transesophageal echocardiography in right-sided endocarditis. J Am Coll Cardiol 1993;21:1926-30.
8. Vuille C, Nidorf M, Weyman AE, et al. Natural history of vegetations during successful medical treatment of endocarditis. Am Heart J 1994;128:1200-9.
9. Rohmann S, Erbel R, Darius H, et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr 1991;4:465-74.
10. DeCastro S, d'Armati G, Bartoni D, et al. Valvular perforation in left-sided infective endocarditis. Am Heart J 1997;134:656-64.
11. Piper C, Hetzer R, Korfer F, et al. The importace of secondary mitral valve involvement in primary aortic valve endocarditis: the mitral kissing vegetation. Eur Heart J 2002;23:79-86.
12. Reynolds HR, Jagen MA, Runick PA, et al. Sensitivity of transthoracic versus transesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr 2003;16:67-70.
13. Afridi I, Apostolidou MA, Saad RM, et al. Pseudoanerysms of the mitral-aortic intervalvular fibrosa: dynamic characterization using transesofageal echocardiographic and Doppler techniques. J Am Coll Cardiol 1995;25:137-45.
14. Horstkotte D. Mikrobiell verursachte Endokarditis. Darmstadt: Steinkopff, 1995.
15. Hardy DJ, Hulbert BB, Migneault PC. Time to detection of positive BacT/ Alert blood cultures and lack of need for routine subculture of 5- to 7-day negative cultures. J Clin Microbiol 1992;30:2743-9.
16. Wilson ML, Mirrett S, Reller LB, et al. Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis 1993;16:31-4.
17. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
18. Goldenberger D, Kunzil A, Vogt P, et al. Molecular diagnosis of bacterial endocarditis using broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997;35:2733-9.
19. Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: Can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002;34:159-66.
20. Gutschik E, and the Endocarditis Working Group. Microbiological recommendations for the diagnosis and follow-up infective endocarditis. Clin Microbiol Infect 1998;4 (Suppl 3):S10-S16.
21. Tornos P, Almirante B, Mirabet S, et al. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999;159:473-5.
22. Kupferwasser LI, Yeaman MR, Shapiro SM, et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplateletand antibacterial effects. Circulation 1999;99:2791-7.
23. Chan KL, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003;42:775-80.
24. Salgado AV, Furian AJ, Keys TF, et al. Neurological complications of endocarditis: a 12-year experience. Neurology 1989;39:173-8.
25. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489-95.
26. Clare CE, Barow DI. Infectious intracranial aneurysms. Neurosurg Clin N Am 1992;3:551-66.
27. Chapot R, Houdart E, Saint-Maurice JP, et al. Endovascular treatment of cerebral mycotic aneurysms. Radiology 2002;222:389-96.
28. Freeman R. Prevention of prosthetic valve endocarditis. J Hosp Infect 1995;30 (Suppl):44-53.
29. Gutschick E. New developments in the treatment of infective endocarditis and infective endovasculitis. Int J Antimicrobial Agents 1999; 13:79-83.
30. Horstkotte D, Schulte HD, Niehues R, et al. Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 1993;2:512-22.
31. Borrow K, Green LH, Mann T, et al. End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. Am J Med 1980;68:655-63.
32. McGiffin DC, Galbraith AJ, Mc Lachlan GJ, et al. Aortic valve infection. Risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992;104:511-20.
33. Jault F, Gandjbakhch I, Chastre JC, et al. Prosthetic valve endocarditis with ring abscesses. Surgical management and long term results. J Thorac Cardiovasc Surg 1993;105:1106-13.
34. Prat A, Fabre OH, Vincentelli A, et al. Ross operation and mitral homograft for aortic and tricuspid valve endocarditis. Ann Thorac Surg 1998;65:1450-2.
35. Haydock D, Barratt Boyes B, Macedo T, et al. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1992;103:130-9.
36. Guerra JM, Tornos MP, Parmanyer-Miralda G, et al. Long term results of mechanical prostheses for treatment of active infective endocarditls. Heart 2001;86:63-8.
37. Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, et al. Prosthetic valve endocarditis: Analysis of risk factors for mortality. Eur J Cardiothorac Surg 1994;8:420-4.
38. Leprince P, Nataf P, Cacoub P, et al. Septicemia and endocarditis related to transvenous pacing leads of pacemakers: surgical indications and results. Arch Mad Coeur Vaiss 1995;88:241-6.
39. Delahaye F, Ecochard R, de Gevigney G, et al. The long term prognosis of infective endocarditis. Eur Heart J 1995; 16 (Suppl B):48-53.
40. Tornos P, Almirante B, Olona M, et al. Clinical outcome and long term prognosis of late prosthetic valve endocarditis: A 20-year experience, Clin Infect Dis 1997;24:381-6.
41. Rechmann P, Seewald M, Thomas L, et al. Untersuchungen zur Bacteriämie bei Zahnärztlichen Eingriffen. Dtsch zahnarzfl Z 1986;41:996-9.
42. van der Meer JMT, Thompson J, Vankenburg HA, Michel MF. Epidemiology of bacterial endocarditis in Netherlands. II. Antecedent procedures and use of prophylaxis. Arch Intern Med 1992;152:1869-73.
43. Durack DT. Prevention of infective endocarditis. New Engl J Med 1995;332:38-44.
44. Botoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc 1986;32:342-6.